The global burden of tuberculosis mortality in children: a mathematical modelling study
Peter J Dodd, Courtney M Yuen, Charalambos Sismanidis, James A Seddon, Helen E Jenkins, Peter J Dodd, Courtney M Yuen, Charalambos Sismanidis, James A Seddon, Helen E Jenkins
Abstract
Background: Tuberculosis in children is increasingly recognised as an important component of the global tuberculosis burden, with an estimated 1 million cases in 2015. Although younger children are vulnerable to severe forms of tuberculosis disease, no age-disaggregated estimates of paediatric tuberculosis mortality exist, and tuberculosis has never been included in official estimates of under-5 child mortality. We aimed to produce a global mortality burden estimate in children using a complementary approach not dependent on vital registration data.
Methods: In this mathematical modelling study, we estimated deaths in children younger than 5 years and those aged 5-14 years for 217 countries and territories using a case-fatality-based approach. We used paediatric tuberculosis notification data and HIV and antiretroviral treatment estimates to disaggregate the WHO paediatric tuberculosis incidence estimates by age, HIV, and treatment status. We then applied systematic review evidence on corresponding case-fatality ratios.
Findings: We estimated that 239 000 (95% uncertainty interval [UI] 194 000-298 000) children younger than 15 years died from tuberculosis worldwide in 2015; 80% (191 000, 95% UI 132 000-257 000) of these deaths were in children younger than 5 years. More than 70% (182 000, 140 000-239 000) of deaths occurred in the WHO southeast Asia and Africa regions. We estimated that 39 000 (17%, 23 000-73 000) paediatric tuberculosis deaths worldwide were in children with HIV infections, with 31 000 (36%, 19 000-59 000) in the WHO Africa region. More than 96% (230 000, 185 000-289 000) of all tuberculosis deaths occurred in children not receiving tuberculosis treatment.
Interpretation: Tuberculosis is a top ten cause of death in children worldwide and a key omission from previous analyses of under-5 mortality. Almost all these deaths occur in children not on tuberculosis treatment, implying substantial scope to reduce this burden.
Funding: UNITAID, National Institutes of Health, and National Institute for Health Research.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures
References
- Liu L, Oza S, Hogan D. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388:3027–3035.
- United Nations Millennium Development Goals and Beyond. 2015. (accessed Jan 23, 2017).
- United Nations Transforming our world: the 2030 Agenda for Sustainable Development. 2015. (accessed Jan 23, 2017).
- WHO . Global tuberculosis report 2015. World Health Organization; Geneva: 2015.
- WHO . Global tuberculosis report 2016. World Health Organization; Geneva: 2016.
- Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014;2:e453–e459.
- Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infect Dis. 2016;16:1193–1201.
- Jenkins HE, Tolman AW, Yuen CM. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet. 2014;383:1572–1579.
- Oliwa JN, Karumbi JM, Marais BJ, Madhi SA, Graham SM. Tuberculosis as a cause or comorbidity of childhood pneumonia in tuberculosis-endemic areas: a systematic review. Lancet Respir Med. 2015;3:235–243.
- Graham SM, Sismanidis C, Menzies HJ, Marais BJ, Detjen AK, Black RE. Importance of tuberculosis control to address child survival. Lancet. 2014;383:1605–1607.
- Gupta M, Rao C, Lakshmi PV, Prinja S, Kumar R. Estimating mortality using data from civil registration: a cross-sectional study in India. Bull World Health Organ. 2016;94:10–21.
- Rao C, Osterberger B, Anh TD, MacDonald M, Chuc NT, Hill PS. Compiling mortality statistics from civil registration systems in Viet Nam: the long road ahead. Bull World Health Organ. 2010;88:58–65.
- Glaziou P, Sismanidis C, Pretorius C, Floyd K. Methods used by WHO to estimate the Global burden of tuberculosis disease. (accessed August 1, 2017).
- Misganaw A, Mariam DH, Araya T, Aneneh A. Validity of verbal autopsy method to determine causes of death among adults in the urban setting of Ethiopia. BMC Med Res Methodol. 2012;12:130.
- Yang G, Rao C, Ma J. Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol. 2006;35:741–748.
- Setel PW, Whiting DR, Hemed Y. Validity of verbal autopsy procedures for determining cause of death in Tanzania. Trop Med Int Health. 2006;11:681–696.
- Jenkins HE, Yuen CM, Rodriguez CA. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17:285–295.
- Dodd PJ, Prendergast AJ, Beecroft C, Kampmann B, Seddon JA. The impact of HIV and antiretroviral therapy on tuberculosis risk in children: a systematic review and meta-analysis. Thorax. 2017;72:559–575.
- Morris DE, Oakley JE, Crowe JA. A web-based tool for eliciting probability distributions from experts. Environmental Modelling & Software. 2014;52:1–4.
- R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (accessed Jan 23, 2017).
- Stevens GA, Alkema L, Black RE. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. PLoS Med. 2016;13:e1002056.
- Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One. 2011;6:e17601.
- Abubakar I, Pimpin L, Ariti C. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis. Health Technol Assess. 2013;17:1–372.
- Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014;14:91.
- Yuen CM, Jenkins HE, Chang R, Mpunga J, Becerra MC. Two methods for setting child-focused tuberculosis care targets. Public Health Action. 2016;6:83–96.
- Hill PC, Rutherford ME, Audas R, van Crevel R, Graham SM. Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries. PLoS Med. 2011;8:e1001105.
- UNAIDS Children and HIV. 2016. (accessed June 8, 2017).
Source: PubMed